מרצים

Prof. Dr. Sven Francque obtained his MD at the University of

Antwerp, Belgium, in 1994 and was subsequently trained in internal medicine and in gastroenterology and hepatology at the Antwerp University Hospital, Belgium and at the Department of Hepatology of the Beaujon hospital, Clichy, France. He has a long-standing interest and expertise in non-alcoholic fatty liver disease and conducted basic research focusing on the vascular changes in steatosis and their contribution to disease progression and leading to his PhD in 2011. His research unit continues to study pathophysiological mechanisms of NASH. He is also conducting clinical research and his unit is partner in several research consortia supported by the European Commission. He participates in several clinical trials in the field and was/is as scientific committee member involved in the design of several phase 2 and phase 3 trials in NAFLD. He  is senior clinical researcher for the Research Fund of the Flemish government. He is currently chairman of the Department of Gastroenterology and Hepatology of the University Hospital Antwerp and professor of medicine at the Faculty of Medicine and Health Sciences of the University of Antwerp

Director of the Centre for Liver and Gastrointestinal Research & Professor of Hepatology, University of Birmingham, and Consultant Hepatologist at the Liver Unit, Queen Elizabeth Hospital, Birmingham

Deputy Director for the Birmingham NIHR Biomedical Research Centre (BRC)

Director of the Midlands & Wales Advanced Therapy Treatment Centre

Vice-Secretary of the European Association for the Study of Liver

He runs the metabolic services at the Liver Unit at the Queen Elizabeth Hospital Birmingham which includes a large multi-disciplinary clinic for patients with NAFLD. Professor Newsome has published over 100 research papers in scientific journals as well as many book chapters in the field of Non-Alcoholic Fatty Liver Disease (NAFLD). He was Chief Investigator on a randomised controlled trial of Glucagon-like peptide-1 (GLP-1) therapy in NAFLD published in the Lancet, and is also Chief Investigator on a study of Fibroscan in NAFLD. He is the Co-ordinating Investigator for several global NAFLD studies. He is editor of a recently published textbook on Liver Transplantation, chaired the national guidelines for liver transplantation in NAFLD and sat on the NICE Guideline Development Group for NAFLD. He led the recent UK multi-stakeholder guideline group on the management of abnormal liver blood tests.

This research portfolio has led to high impact publications throughout including both original articles (PNAS, Gastroenterology, Hepatology, Journal of Hepatology, Gut, American Journal of Transplantation, Annals of Internal Medicine, Lancet) and review articles (FASEB, Gastroenterology, Journal of Hepatology).

Born in Milan on 10/04/1966

Associate Professor of Pediatric at the University “La Sapienza” in Rome-Italy
Actually, he is the Head of Hepatology, Gastroenterology, and Nutrition Unit and the Chief of Liver and Gut Research Unit at the Bambino Gesù Children Hospital in Rome, Italy
He is a member of ESPGHAN, EASL, AASLD and member of the Board of MEDSCAPE Gastroenterology.

He is reviewer for the following medical  Journal: Hepatology, GUT, Journal Gastroenterology and Hepatology, Journal Pediatric Gastroenterology and Nutrition, World Journal Gastroenterology, Journal of Hepatology, Liver International, Pediatric Transplantation, Expert Review of Molecular Diagnostics, Journal of Hematology, Journal of Internal Medicine, Journal of Clinical Rheumatology, Clinical Endocrinology. For the Pediatric Obesity, Digestive Disease, Digestive Liver Disease Journal he’s an Associate Editor

He has published more than 350 works in international reviews several book’s chapter and he has attended many national  and international Congresses as Speaker.

Dr. Marra graduated cum laude in 1986 at the University of Florence, School of Medicine. He received his Ph.D. Degree in 1992, with studies on the pathophysiology of cirrhosis. From 1992 to 1994 he has been Post-doctoral Fellow in the Department of Medicine, University of Texas Health Science Center at San Antonio USA. In 1995 Dr. Marra has been appointed at the University of Florence, School of Medicine, where he leads an independent research group, and is currently Professor of Medicine and Vice President for Clinical Medicine and Healthcare. In addition to his research activity, Dr. Marra is involved in clinical work and teaching in the Department of Medicine.

From 2002 to 2005 Dr. Marra has been a member of the Steering Committee of the Italian Association for the Study of the Liver (AISF). From 2007 to 2010 he has been a member of the Governing Board of the European Association for the Study of the Liver (EASL). He has been part of the Future Trends Committee for the United European Gastroenterology (UEG). He has published more than 190 papers on peer-reviewed journals (h-index Scopus = 66). He is currently Associate Editor of Journal of Hepatology, and is or has been a member of the Editorial Board of major international journals, including Gastroenterology, Hepatology, Clinical Science, American Journal of Physiology – GI & Liver. Dr. Marra regularly serves as a reviewer for prestigious Gastroenterology journals and for funding agencies.

Dr. Marra’s group has provided a relevant scientific contribution to several fields of Hepatology, including the pathophysiology of nonalcoholic steatohepatitis, cellular and molecular mechanisms of hepatic inflammation and fibrogenesis, and non-invasive evaluation of liver fibrosis. His current interests also include pathogenesis and treatment of hepatocellular carcinoma.